Related references
Note: Only part of the references are listed.Clinical experience of convection-enhanced delivery (CED) of carboplatin and sodium valproate into the pons for the treatment of diffuse intrinsic pontine glioma (DIPG) in children and young adults after radiotherapy
Elwira Szychot et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2021)
Pediatric Glioma: An Update of Diagnosis, Biology, and Treatment
Yusuke Funakoshi et al.
CANCERS (2021)
Oncolytic HSV-1 G207 Immunovirotherapy for Pediatric High-Grade Gliomas
G. K. Friedman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
WHO classification of tumors of the nervous system: preview of the upcoming 5th edition
Elisabeth J. Rushing
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY (2021)
Implications of new understandings of gliomas in children and adults with NF1: report of a consensus conference
Roger J. Packer et al.
NEURO-ONCOLOGY (2020)
B7-H3 as a Prognostic Biomarker and Therapeutic Target in Pediatric central nervous system Tumors
Uday B. Maachani et al.
TRANSLATIONAL ONCOLOGY (2020)
Personalized Treatment of H3K27M-Mutant Pediatric Diffuse Gliomas Provides Improved Therapeutic Opportunities
Johannes Gojo et al.
FRONTIERS IN ONCOLOGY (2020)
Integrated Molecular and Clinical Analysis of 1,000 Pediatric Low-Grade Gliomas
Scott Ryall et al.
CANCER CELL (2020)
Advances in the molecular classification of pediatric brain tumors: a guide to the galaxy
Chantel Cacciotti et al.
JOURNAL OF PATHOLOGY (2020)
Pediatric low-grade glioma in the era of molecular diagnostics
Scott Ryall et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2020)
Disialoganglioside GD2 Expression in Solid Tumors and Role as a Target for Cancer Therapy
Bassel Nazha et al.
FRONTIERS IN ONCOLOGY (2020)
CAR T Cell Therapy for Pediatric Brain Tumors
John D. Patterson et al.
FRONTIERS IN ONCOLOGY (2020)
Blood-Brain Barrier Disruption in Neuro-Oncology: Strategies, Failures, and Challenges to Overcome
Brij S. Karmur et al.
FRONTIERS IN ONCOLOGY (2020)
Outcomes of BRAF V600E Pediatric Gliomas Treated With Targeted BRAF Inhibition
Liana Nobre et al.
JCO PRECISION ONCOLOGY (2020)
Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial
Jason Fangusaro et al.
LANCET ONCOLOGY (2019)
Towards Immunotherapy for Pediatric Brain Tumors
Stacie Shiqi Wang et al.
TRENDS IN IMMUNOLOGY (2019)
A single-center study of the clinicopathologic correlates of gliomas with a MYB or MYBL1 alteration
Jason Chiang et al.
ACTA NEUROPATHOLOGICA (2019)
Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas
Ana S. Guerreiro Stucklin et al.
NATURE COMMUNICATIONS (2019)
Efficacy and Safety of Dabrafenib in Pediatric Patients with BRAF V600 Mutation-Positive Relapsed or Refractory Low-Grade Glioma: Results from a Phase I/IIa Study
Darren R. Hargrave et al.
CLINICAL CANCER RESEARCH (2019)
cIMPACT-NOW update 4: diffuse gliomas characterized by MYB, MYBL1, or FGFR1 alterations or BRAFV600E mutation
David W. Ellison et al.
ACTA NEUROPATHOLOGICA (2019)
PD-L1 expression and tumor mutational burden are independent biomarkers in most cancers
Mark Yarchoan et al.
JCI INSIGHT (2019)
BRAF V600E Status Alone Is Not Sufficient as a Prognostic Biomarker in Pediatric Low-Grade Glioma
David T. W. Jones et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M+ diffuse midline gliomas
Christopher W. Mount et al.
NATURE MEDICINE (2018)
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011-2015
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2018)
Pediatric high-grade glioma: a review of biology, prognosis, and treatment
Abhishek Bavle et al.
JOURNAL OF RADIATION ONCOLOGY (2018)
Announcing cIMPACT-NOW: the Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2017)
A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma - A final report
Astrid K. Gnekow et al.
EUROPEAN JOURNAL OF CANCER (2017)
Pediatric Gliomas: Current Concepts on Diagnosis, Biology, and Clinical Management
Dominik Sturm et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas
Alvaro Lassaletta et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
K27M-mutant histone-3 as a novel target for glioma immunotherapy
Katharina Ochs et al.
ONCOIMMUNOLOGY (2017)
Histologically distinct neuroepithelial tumors with histone 3 G34 mutation are molecularly similar and comprise a single nosologic entity
Andrey Korshunov et al.
ACTA NEUROPATHOLOGICA (2016)
Gliomatosis cerebri in children shares molecular characteristics with other pediatric gliomas
Alberto Broniscer et al.
ACTA NEUROPATHOLOGICA (2016)
Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology
Ibrahim Qaddoumi et al.
ACTA NEUROPATHOLOGICA (2016)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Systematic MRI in NF1 children under six years of age for the diagnosis of optic pathway gliomas. Study and outcome of a French cohort
Gaelle Blanchard et al.
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2016)
Phase II Weekly Vinblastine for Chemotherapy-Naive Children With Progressive Low-Grade Glioma: A Canadian Pediatric Brain Tumor Consortium Study
Alvaro Lassaletta et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
Eric Bouffet et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Recurrent MET fusion genes represent a drug target in pediatric glioblastoma
Sebastian Bender et al.
NATURE MEDICINE (2016)
Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes
David Castel et al.
ACTA NEUROPATHOLOGICA (2015)
High frequency of H3F3A K27M mutations characterizes pediatric and adult high-grade gliomas of the spinal cord
Marco Gessi et al.
ACTA NEUROPATHOLOGICA (2015)
BRAF Mutation and CDKN2A Deletion Define a Clinically Distinct Subgroup of Childhood Secondary High-Grade Glioma
Matthew Mistry et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
KIAA1549: BRAF Gene Fusion and FGFR1 Hotspot Mutations Are Prognostic Factors in Pilocytic Astrocytomas
Aline Paixao Becker et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2015)
Childhood and adolescent cancer statistics, 2014
Elizabeth Ward et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
The NF1 gene revisited - from bench to bedside
Yoon-Sim Yap et al.
ONCOTARGET (2014)
Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge
Dominik Sturm et al.
NATURE REVIEWS CANCER (2014)
Reduced H3K27me3 and DNA Hypomethylation Are Major Drivers of Gene Expression in K27M Mutant Pediatric High-Grade Gliomas
Sebastian Bender et al.
CANCER CELL (2013)
B7-H3, a potential therapeutic target, is expressed in diffuse intrinsic pontine glioma
Zhiping Zhou et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma
David T. W. Jones et al.
NATURE GENETICS (2013)
Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas
Jinghui Zhang et al.
NATURE GENETICS (2013)
Paradoxical activation and RAF inhibitor resistance of BRAF protein kinase fusions characterizing pediatric astrocytomas
Angela J. Sievert et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Inhibition of PRC2 Activity by a Gain-of-Function H3 Mutation Found in Pediatric Glioblastoma
Peter W. Lewis et al.
SCIENCE (2013)
BRAF-KIAA1549 Fusion Predicts Better Clinical Outcome in Pediatric Low-Grade Astrocytoma
Cynthia Hawkins et al.
CLINICAL CANCER RESEARCH (2011)
Fibroblast growth factor signalling: from development to cancer
Nicholas Turner et al.
NATURE REVIEWS CANCER (2010)
Outcome and Prognostic Features in Pediatric Gliomas A Review of 6212 Cases From the Surveillance, Epidemiology, and End Results Database
Ibrahim Qaddoumi et al.
CANCER (2009)
Tandem Duplication Producing a Novel Oncogenic BRAF Fusion Gene Defines the Majority of Pilocytic Astrocytomas
David T. W. Jones et al.
CANCER RESEARCH (2008)
BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas
Stefan Pfister et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
The contrasting role of B7-H3
Kimberly A. Hofmeyer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
B7-H3:: A costimulatory molecule for T cell activation and IFN-γ production
AI Chapoval et al.
NATURE IMMUNOLOGY (2001)
Share Paper
